Radioiodine-Induced Thyrotoxicosis and Thyroiditis After Ablative Therapy for Papillary Carcinoma
- 1 October 1999
- journal article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 24 (10) , 741-3
- https://doi.org/10.1097/00003072-199910000-00001
Abstract
The preferred treatment for patients with multifocal thyroid carcinoma or a single focus of malignancy larger than 1.5 cm is near-total thyroidectomy followed by radioiodine ablation therapy of the remaining thyroid tissue. The authors describe a patient who had a 2.6-cm papillary thyroid carcinoma but no evidence of metastatic disease. This malignancy was not diagnosed during intraoperative frozen section examination, but rather at the final pathologic analysis. The unilateral thyroid lobectomy resulted in a recurrent laryngeal nerve palsy. During subsequent I-131 therapy of the remaining lobe, features of acute radiation thyroiditis, including thyrotoxicosis, developed.Keywords
This publication has 5 references indexed in Scilit:
- Radioiodine Therapy for Thyroid CancerEndocrinology and Metabolism Clinics of North America, 1995
- Ablation of Remaining Functioning Thyroid Lobe With Radioiodine After Hemithyroidectomy for CarcinomaClinical Nuclear Medicine, 1993
- Oedema of the neck after ablation of the thyroid with radioactive iodineThe British Journal of Radiology, 1986
- The Ablation of Normal Thyroid Tissue with Iodine 131The British Journal of Radiology, 1963
- RADIOACTIVE IODINE THERAPYJAMA, 1946